/** blogpostTitle: Meenakshi India Q1 FY27: PAT spike, margin reset, and a bigger capacity plan blogpostSlug: meenakshi-q1 blogpostShortTitle: Meenakshi India Q1 FY27 earnings snapshot blogpostCoverImageDescription: An ultra-realistic corporate finance scene showing a clean dashboard on a laptop with three simple charts: a quarterly revenue line trending from about 33 to 46 and back near 32 (in INR crore), a bar chart comparing operating EBITDA and PAT for three quarters with PAT much higher in the latest quarter, and a donut chart for FY26 geographic revenue mix highlighting Europe as the largest portion. The background includes a modern apparel factory floor blurred out, suggesting manufacturing, with neutral lighting and no readable text. */

Meenakshi India Q1 FY27: PAT spike, margin reset, and a bigger capacity plan

Meenakshi (India) Limited entered the public market conversation just weeks after its equity shares were listed on BSE in July 2026 under the direct listing route. The first earnings call for Q1 FY27 therefore had two jobs: explain the quarter, and explain what kind of apparel manufacturer the company wants to be.

For the quarter ended June 30, 2026, revenue from operations came in at INR 32.25 crore. Operating EBITDA was INR 1.10 crore. Profit after tax was INR 7.13 crore, materially higher than the prior year quarter. On the face of it, the profit profile looks unusual: the company reported a PAT margin of 22% in the investor presentation for Q1 FY27.

Management addressed the why. A large part of the quarter’s profitability was supported by other income, including unrealized fair value gains on investments and gains linked to foreign currency forward contracts. Management described these items as market-linked and potentially non-recurring. The message was direct: investors should separate the factory’s operating momentum from treasury-driven volatility.

Q1 FY27: operating improvement under tariff pressure

The quarter’s topline was influenced by external demand conditions. The company stated that revenue was affected by tariff-related uncertainty in the US and slower demand in Europe. That context matters because Meenakshi positions itself in the premium segment of woven bottom wear and outerwear, supplying a relatively concentrated set of global brands.

Despite the softer revenue, management highlighted a sharp improvement in the operating performance of the garment business. In the concall, the company stated that operating profit from the textile segment improved to INR 3.43 crore from INR 0.28 crore in the same quarter last year, attributing the shift to better product mix, pricing discipline, and cost control.

Cost behaviour also moved in the right direction in Q1 FY27. Total expenses were stated at INR 31.72 crore. Material cost (net of inventory changes) was INR 14.72 crore, or about 45.7% of revenue, improving from roughly 48% in the same quarter last year. Employee costs were described as broadly flat year-on-year at INR 8.94 crore. Other expenses were INR 7.47 crore.

The company also reiterated its low leverage profile. Finance cost for the quarter was about INR 0.10 crore. Management stated borrowings were under INR 1 crore and that cash, bank balances, and investments were approximately INR 80 crore at the last balance sheet day.

Note: Management highlighted that Q1 FY27 other income included unrealized investment gains and forex forward related gains, which may not recur.

FY26 versus FY25: the base effect and the tariff year

The annual numbers show why management keeps returning to the idea of normalization. FY26 revenue from operations was INR 150.8 crore, compared with INR 166.3 crore in FY25. Operating EBITDA in FY26 was INR 10.8 crore versus INR 29.5 crore in FY25. PAT was INR 10.5 crore in FY26 versus INR 39.1 crore in FY25.

The investor presentation explicitly attributes a large part of the FY25 profitability to a one-time exceptional gain of INR 12.5 crore from the sale of plantation land. Management repeated this point on the concall, stating FY25 gross revenue was higher because of this exceptional item. The year-on-year optics therefore include both a base effect and a demand effect.

The second driver was tariffs. Management described the US tariff situation as disruptive and said it affected demand during FY26. On the call, the company also explained why being “premium” does not eliminate tariff impact. Tariffs raise landed prices, and management stated it partnered with customers through pricing and discounts to retain relationships.

Strategy: capacity, country-of-origin flexibility, and product adjacencies

The company’s strategic narrative is built around a premium positioning. Management said it deliberately focuses on premium bottom wear because competing in mass-market categories against Bangladesh and Vietnam is structurally difficult. Instead, it wants to compete with higher-value manufacturing hubs.

The next leg of growth is planned capacity addition. The presentation outlines a three-phase expansion across FY28, FY29 and FY30, targeting an increase in total capacity from 18 lakh units per annum to 37.5 lakh units per annum by FY2030(E). The same slide projects FY30 revenue of around INR 500 crore and PAT of around INR 65 crore.

On the concall, management discussed the investment envelope behind this plan. The CFO indicated one factory is planned for 2028 with an estimated cost of about INR 20 crore, with the second factory discussed around FY30 at a similar cost. Management later described the capex as ballpark and suggested INR 40 to 50 crore up to FY30.

Capacity utilization was also framed carefully. The company cites 65% utilization in the presentation, but management clarified that utilization is sensitive to product mix and cannot be read as a simple “unused factory space” number. The company stated it aims to plan around 80% utilization due to seasonality. For FY27, management indicated an expectation of close to 70% utilization.

A second strategic pillar is risk management through geographic options. The presentation notes an MoU with a Sri Lankan company for contract manufacturing to mitigate geopolitical risk. It also mentions early-stage evaluation for expansion into Nepal, Vietnam, Sri Lanka and other markets.

In the concall, management clarified the intent: Sri Lanka is positioned as a contingency option, primarily for an adverse tariff scenario affecting goods made in India. Nepal was described as a more structural diversification opportunity, supported by labour availability and capability, in response to policy volatility.

The company is also widening the product portfolio. The investor presentation states it is expanding beyond premium men’s bottom wear into adjacent categories, including women’s wear, evaluating athleisure, and evaluating entry into D2C.

Management explained that women’s wear bottoms are a relatively natural adjacency because manufacturing complexity is similar to men’s bottoms. For athleisure, management stated the capability is not about a dedicated plant, but about strengthening sourcing and operator handling for relevant fabrics. The company said it already has some man-made fibre sourcing through India, China and other countries and plans to develop that base further.

D2C, however, is paused. Management stated it ran a test phase but put the initiative on hold due to a patent issue related to the name SHORTSTOP.

What investors should track from here

The Q1 FY27 print is a mix of two stories. First, operating performance in the garment business improved on similar revenue, supported by cost control and product mix. Second, reported PAT was meaningfully supported by other income that management itself described as variable and potentially non-recurring.

Looking ahead, the company’s forward narrative rests on three measurable levers that were stated in the documents: a planned scale-up in capacity through FY30, a target to move operating margins back toward historical levels with a stated ambition of around 17% EBITDA margin by FY28, and risk mitigation through alternative country-of-origin options.

The balance sheet profile is an important part of execution credibility. Management stated the company is effectively debt-free with substantial liquidity, which should provide flexibility as it invests through a phased capex program.

The next few quarters should therefore be read through a simple lens: how quickly the operating EBITDA margin normalizes, how stable demand remains amid tariff and geopolitical uncertainty, and how the company converts its capacity expansion roadmap into commissioned, utilized production without losing its premium positioning.